Navigation Links
Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe
Date:3/31/2012

Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards aim to guide clinicians and public health workers to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe with nearly 74,000 reported TB cases in the EU/EEA in 2010 clearly showing that TB remains a public health challenge across the region.

The new EU-specific guidelines were developed by a panel of 30 experts and aim to bridge current gaps in the case management of TB that were identified in a recent survey. In the process, the ERS has taken the lead in developing the clinically related standards and ECDC has developed the public health related standards. The ESTC are based on the same recommendations as the International Standards for TB Care (ISTC), but feature additional supplements and replacement information relevant for healthcare providers in the EU.

EU-specific recommendations from the new guidelines include:

  • All people showing signs, symptoms, history or risk factors linked with TB should be examined for TB.
  • All people diagnosed with TB should undergo drug susceptibility testing in a laboratory setting, to rule out drug-resistance and help combat the growing number of multidrug-resistant cases of TB (MDR-TB).
  • Patients with, or highly likely to have, TB caused by drug-resistant organisms (especially MDR-TB) should be treated for at least 20 months, with the recommended intensive phase of treatment being 8 months.
  • Clinicians should ensure that all newly admitted patients who are suspected of having infectious TB are subject to respiratory isolation until their diagnosis is confirmed or excluded following an appropriate infection control plan.

The guidelines also include an additional section on how policymakers and healthcare professionals can adopt and introduce the recommendations to a healthcare setting.

"Multidrug-resistant and extensively drug-resistant TB have taken a foothold in the EU: 4.6% of the TB patients were diagnosed with MDR-TB in 2010 and only 30% of the MDR TB patients notified in 2008 have been successfully treated and the proportion of XDR-TB patients increased from 8.2% to 13.2% from 2009 to 2010," warns ECDC Director Marc Sprenger. "We have to do better than that and actively prevent drug-resistant TB. To do this, the new EU Standards offer hands-on and easy-to-use advice tailored to the needs of the EU/EEA. It is every TB patient's right to receive the best of care and we have a responsibility towards EU/EEA citizens to prevent any more spread of TB, MDR-TB and XDR-TB."

President-elect of the ERS, Professor Francesco Blasi, who is also an author of the new guidelines, said: "Across Europe, TB poses a serious threat to public health. With accurate prevention, diagnosis and treatment, we can diminish this threat. Standards for TB care in Europe are still below an acceptable level and recent surveys have highlighted gaps in the case management of TB. The new guidelines include key recommendations relevant to a European audience, which can help reduce the spread of TB and improve patient care."

The publication of the guidelines coincides with the start of a special review series in the European Respiratory Journal, looking at the current state of TB in Europe. The series begins today with an editorial and paper on the prevalence of inappropriate TB treatment regimens. Four more papers will follow in upcoming editions of the Journal.

The ERS has also recently launched (early March) the European Forum for TB Innovation which aims to identify and highlight the gaps, challenges and needs in innovating and optimising European and global TB control.


'/>"/>
Contact: Lauren Anderson
lauren.anderson@europeanlung.org
44-114-267-2876
European Lung Foundation
Source:Eurekalert

Related medicine news :

1. Towards more effective treatment for multiple myeloma
2. Transending Borders Towards Global Health
3. Steps being taken towards achieving an early diagnosis of cancer of the large intestine
4. Steps towards the use of adult stem cells for gene therapy
5. Top scientists unite to develop global scientific strategy Towards An HIV Cure
6. Warning about benevolent sexism and mens apparently positive attitudes towards women
7. Study shows behaviors and attitudes towards oral sex are changing
8. PaperFree Florida to help move physicians towards electronic health records
9. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
10. Electronic Health Information Leader Says Physician Practice Redesign is Vital Next Step Towards Safer, More Effective Care Delivery
11. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... While ... Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue while ... Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... BEAVER CREEK, CO (PRWEB) , ... February 17, 2017 , ... ... the second annual International Healing NET Foundation Summit from February 21 - 23 in ... Healing NET Foundation (HNF). This marks the Summit’s second year in Beaver Creek, hosting ...
(Date:2/16/2017)... DC (PRWEB) , ... February 17, 2017 , ... Teaching ... Excellence (ACE) program, now in development. ACE.P (pediatrics) is being created with the support ... the Care of Vulnerable Populations , ACE.P will address what has been identified as ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017 Arvinas LLC, a private ... on protein degradation, today announced the presentation of new ... during a poster session at the American Society of ... Orlando, FL. ... platform and the potential of PROTACs to drive durable ...
(Date:2/17/2017)... --  Risperdal lawsuits involving gynecomastia (male breast growth) ... the atypical antipsychotic medication continue to move forward in ... Pleas, where the state,s Risperdal docket has been centralized ... posted on the Court,s website , the litigation ... 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ...
(Date:2/17/2017)... 2017 On Thursday, February 16, ... lower at the closing bell, while the Dow Jones ... benchmark. Moreover, five out of nine sectors ended Thursday,s ... market sentiment, Stock-Callers.com assessed the following Medical Appliances & ... SNN ), ABIOMED Inc. (NASDAQ: ...
Breaking Medicine Technology: